ONTOZRY 100 mg, film-coated tablet 14 tablets
Active ingredients: Cenobamate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet14 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ONTOZRY 100 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC aluminium de 14 comprimé(s)
- Marketing authorisation holder
- ANGELINI PHARMA (ITALIE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 May 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
61025114CIP73023006CIP133400930230060Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉNOBAMATEcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.